Concepedia

Katie Chon

KC

Statistics

Publications

1

Citations

56

H-Index

1

Active since

2023

Affiliations

United States Food and Drug Administration(Current)

Katie Chon is an author at United States Food and Drug Administration specializing in non-small cell lung cancer treatment, bispecific antibody therapy, and egfr inhibition.

ORCID

Publications per year

2023–2023

1

Publications

1

FDA Approval Summary: Amivantamab for the Treatment of Patients with Non–Small Cell Lung Cancer with <i>EGFR</i> Exon 20 Insertion Mutations

Katie Chon, Erin Larkins, Somak Chatterjee et al. · Clinical Cancer Research · 2023 · 56 citations · Full text

, , +15

1–1 of 1